Pomegra
UnitedHealth Stock Rises 3.5% After Guidance Raise
Why did UnitedHealth stock rise 3.5%?
UnitedHealth (UNH) stock rose 3.5% to about $421.50 on Tuesday as a guidance raise to at least $20.50 per share, helped by lower medical costs, extended its post-earnings rally.
Key numbers
| 2026 adjusted EPS outlook | At least $20.50from $19.50–$20.00 |
|---|---|
| Q3 adjusted EPS | $4.69vs $4.14 expected |
| Medical care ratio | 88.4%from 89.9% a year ago |
| Q3 revenue | $112.7Bvs $113.2B a year ago |
| Optum Health operating margin | 3.2%from 0.2% a year ago |
| UNH share price (Oct 20) | ~$421.50+3.5% on the day (per [4]) |
What happened
UnitedHealth (UNH) stock rose 3.5% to about $421.50 on Tuesday as a guidance raise to at least $20.50 per share, helped by lower medical costs, extended its post-earnings rally. The company said on October 13 it now expects adjusted profit of at least $20.50 per share for 2026, up from $19.50 to $20.00. Adjusted third-quarter profit was $4.69 per share, beating the $4.14 analysts expected. The share of premiums spent on patient care fell to 88.4% from 89.9%, helped by a $610 million one-time reserve release.
Why it matters
UnitedHealth is the largest US health insurer, so its results show how costly medical care is for the whole industry. Lower costs and a stronger Optum, its care and pharmacy arm, suggest its recovery from higher costs last year is working. But it has about 935,000 fewer Medicare Advantage customers than at the end of 2025, and part of the cost gain was a one-time item.
Who this affects
- MarketbullishMedium impact
- Health insurer shares rose; investors gain as profit outlook improves.
- CompanybullishHigh impact
- Shareholders gain as profit outlook rises; shrinking membership remains a risk.
- CompetitorsmixedLow impact
- Humana and Elevance rose about 2%, less than UnitedHealth.
- IndustrymixedMedium impact
- Insurer cost pressure may be easing, but Medicare Advantage enrollment is falling.
UnitedHealth vs Humana, Elevance Health, Centene
How we got here
UnitedHealth reports Q3 results and lifts 2026 profit outlook to at least $20.50 per share.
Shares jump about 4% to $395.19; Humana and Elevance gain about 2%.
Shares rise about 3.5% to roughly $421.50, extending the post-earnings rally.
What to watch
- Management has said it will give a fuller 2027 outlook by year-end.2026-12-31
- Whether Medicare Advantage membership, down 935,000 since end-2025, stops shrinking.Q4 2026
Educational content only. Not investment advice.
More briefsAll briefs →
Dow Rises 1% as Healthcare Stocks Hit Record High
Eli Lilly (LLY) jumped 4.7% to a record as the Dow closed near 52,514, the Nasdaq stayed flat and oil fell.
Western Digital Stock Jumps 6% as Chip Stocks Bounce
Western Digital (WDC) rose 6.09% as the chip index snapped an eight-day slide before Thursday's earnings.
Equifax Stock Jumps 10.5% After Q3 Earnings Beat
Equifax (EFX) beat profit forecasts at $2.26 a share, easing fears about a slump in mortgage-credit demand.